Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001435

Drug Information
SynonymsSBB058565; Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl; MLS001335937; HMS2093L17; Ster Zac Bath Concentrate; UNII-4NM5039Y5X; Aquasept; D014260; AC1L1KMN; Microshield T; CPD0-1227; Oxy Skin Wash; MLS001074876; Irgasan DP300; SAM002554907; 72779_SIGMA; Triclosanum; SMR000471847; Phenyl ether, 2'-hydroxy-2,4,4'-trichloro-; CH-3565; HSDB 7194; 112099-35-1; 2,4,4'-Trichloro-2'-hydroxy diphenyl ether; 88032-08-0; SSL Brand of Triclosan; 72779_FLUKA; TL8002539; TCL; Stri-Dex Cleansing Bar; EINECS 222-182-2; CPD000471847; D06226; Dermtek Brand of Triclosan; Caswell No. 186A; Cloxifenol; Cloxifenolum; Triclosan (USP/INN); Trans Canaderm Brand of Triclosan; 2,4,4'-Trichloro-2'-hydroxydiphenyl ether; NCGC00159417-04; CH 3565; Lexol 300; S00100; BRN 2057142; C12059; 261921-78-2; NCGC00159417-02; Clearasil Daily Face Wash; MLS001066347; 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL; DB08604; DP-300; CID5564; MolPort-003-666-702; Procter & Gamble Brand of Triclosan; CCRIS 9253; EPA Pesticide Chemical Code 054901; Sapoderm; Triclosanum [INN-Latin]; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Manusept; Triclosan Pharmachem Brand; 164325-69-3; Irgasan DP 300; 524190_ALDRICH; Trisan; LS-67854; Triclosan; Irgasan; GlaxoSmithKline Brand of Triclosan; CHEMBL849; Ster-Zac Bath Concentrate; CHEBI:164200; Reckitt Brand of Triclosan; IN1424; Stri-Dex Face Wash; MLS001335938; I01-2897; AC-10667; Pharmachem Brand of Triclosan; 2-Hydroxy-2',4,4'-trichlorodiphenyl Ether; Triclosan [USAN:BAN:INN]; NCGC00159417-03; Johnson & Johnson Brand of Triclosan; 3380-34-5; triclosan; Stri-Dex cleansing bar (TN); C12H7Cl3O2; Triclosan Reckitt Brand; Cliniclean; Irgasan; SterZac Bath Concentrate; Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-
IndicationBacterial infections
[ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104   ICD10: A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl    
Therapeutic ClassAntibacterial Agents
CAS NumberCAS 3380-34-5
PubChem Compound IDCID 5564.
PubChem Substance IDSID 14214.
SuperDrug ATC IDD08AE04; D09AA06
SuperDrug CAS ID003380345;
TargetEnoyl-ACP reductaseBinder[2][3][4]
Ref 1The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. To Reference
Ref 2Novel molecular targets for antimalarial drug development. Chem Biol Drug Des. 2008 Apr;71(4):287-97. Epub 2008 Feb 22. To Reference
Ref 3The apicoplast as an antimalarial drug target. Drug Resist Updat. 2001 Jun;4(3):145-51. To Reference
Ref 4Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res. 2001 Nov;40(6):467-97. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543